The Swedish healthcare provider will sell its India hospital operations to KKR-managed funds as it sharpens its focus on key European markets
Eli Lilly raised its full-year revenue forecast after stronger-than-expected quarterly results, driven by robust demand for Mounjaro and Zepbound
Dr Lal PathLabs' share price jumped 8 per cent to a fresh 52-week high of ₹1,893.65 on the BSE today. The company has posted a better-than-expected Q1 show, prompting analysts to raise target prices.
The Swedish beauty brand will retain its commercial operations in India while entering a long-term manufacturing and supply partnership with Akums
A global survey of nearly 2,800 clinicians finds AI is now part of everyday healthcare, but weak trust, limited training and poor governance threaten its wider adoption in clinical practice
Accel, Elevation Capital and Nexus Venture Partners co-led the Series A round as Plazza expands its AI-powered pharmacy network and inventory intelligence platform
NATHEALTH president also pitches prevention-led insurance, PPPs and a national mission to scale medical value travel
Defence Minister Rajnath Singh on Monday asserted that India is setting new benchmarks in medical research and developing indigenous solutions to global health challenges through gene therapy and nuclear medicine. India's health system is also emerging as more self-reliant, he said addressing the 22nd convocation ceremony of the King George's Medical University, Lucknow. "Today, India's health system has emerged as more self-reliant, accessible, affordable, modern and people-centric as compared to earlier times. Today, India is developing indigenous solutions to global health challenges through gene therapy, nuclear medicine, and other modern technologies," Singh said. The Lok Sabha MP said the country's scientists have successfully demonstrated an indigenous gene therapy for the treatment of haemophilia, while scientists at an institute in Pune have developed a state-of-the-art nanomedicine for treating breast cancer. The 'Production Linked Incentive' scheme, he said, has given fr
Rajasthan's Heal Policy 2025 aims to position the state as a global medical tourism hub with quality healthcare, digital services and investment-friendly incentives
Hospital chain Fortis Healthcare has signed an O&M agreement with Dion Group to operate a 300-bed hospital in Cuttack, marking its entry into Odisha and expanding its eastern India presence
ESIC plans a deemed health sciences university to unify its medical colleges, standardise education, boost research and strengthen governance across its expanding network
Apollo Cancer Centres has partnered with Zydus Lifesciences to introduce Guardant Health's Shield Multi-Cancer Detection blood test, becoming the first healthcare institution in India to offer it
The agreement marks Fortis Healthcare's first major presence in Odisha
State-owned Bank of Baroda (BoB) on Thursday said it reached an out-of-court settlement with NMC Health PLC, NMC Healthcare Ltd, and NMC Holding Ltd, with USD 600 million (about Rs 5,700 crore) paid through its Abu Dhabi Branch. The case involved proceedings under Abu Dhabi Global Market (ADGM) and UK insolvency regulations, and the UAE civil law in relation to NMC Health PLC, NMC Holding Ltd and NMC Healthcare Ltd, BoB said in a regulatory filing. "NMC Health PLC, NMC Healthcare Ltd, NMC Holding Ltd, and their respective Joint Administrators, have resolved the claims between them and the Bank of Baroda in consideration for, inter alia, payment by Bank of Baroda of USD 600 million, pursuant to a settlement agreement," it said. All claims, causes of action, etc. between them have been resolved without admission of liability or wrongdoing, it said. The settlement agreement and its terms otherwise remain confidential, it said, adding that the liability of the bank in these proceedings
The joint venture will invest over $20 million in a pharmaceutical manufacturing facility in Sri Lanka to boost local drug production and reduce reliance on imports
The US drugmaker has launched Tanstrive, a RET-targeted oral therapy for advanced or metastatic solid tumours, following marketing authorisation from the CDSCO
Even before India's air taxi rules are finalised, hospitals and air ambulance operators are partnering with eVTOL startups to transform emergency care
Department of Pharmaceuticals invites stakeholder comments on proposed additions and deletions to the list of medical devices exempted from Global Trade Enquiry requirements
While 95.4 per cent of births now take place in hospitals, nearly half of all deaths occur without qualified medical attention, highlighting a gap in end-of-life care
President Droupadi Murmu on Friday expressed confidence that India would eradicate sickle cell disease well before the 2047 target, and stressed the need for collective efforts to raise awareness and eliminate the genetic blood disorder, particularly among tribal communities. Addressing a state-level programme on World Sickle Cell Day in the pilgrimage town of Omkareshwar in Khandwa district, she also urged all state governments not to take the sickle cell disease lightly. Murmu said the country would achieve its national goal of eliminating the disease much ahead of schedule through the combined strength and active participation of all states. "I am confident that with the collective strength and proactive efforts of all states, we will certainly succeed in achieving our national goal of eliminating sickle cell disease from the country well before 2047," she said. Prime Minister Narendra Modi had launched the National Sickle Cell Anaemia Elimination Mission from Shahdol district o